Transplant Diagnostics Market Growth Patterns And Forecast Outlook Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Transplant Diagnostics Market Between 2026 And 2030?

The transplant diagnostics market has experienced substantial growth in recent years. It is anticipated to expand from $2.07 billion in 2025 to $2.25 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. The expansion observed historically can be attributed to several factors, including the increasing number of organ transplantation procedures, progress in histocompatibility testing, a rising incidence of immunogenetic disorders, the proliferation of transplant centers, and government funding for organ donation programs.

The transplant diagnostics market size is projected to experience robust expansion in the coming years, reaching $2.96 billion by 2030 with a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is propelled by factors such as the integration of AI and machine learning into testing, the increasing adoption of next-generation sequencing (NGS), the expansion of personalized immunotherapy, the development of cloud-based diagnostics platforms, and a rise in global organ donation awareness. Significant trends expected in this period include rapid histocompatibility testing, AI-powered donor-recipient matching, enhanced molecular diagnostics integration, high-throughput screening techniques, and cloud-based systems for transplant data management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Which Drivers Are Supporting The Transplant Diagnostics Market Growth?

The escalating incidence of chronic illnesses is projected to stimulate the expansion of the transplant diagnostics market in the future. Chronic diseases are persistent health conditions that typically advance slowly over time, such as diabetes, heart disease, and arthritis, frequently demanding continuous medical care and lifestyle adjustments for symptom control and complication prevention. The rise in chronic diseases is largely attributable to unhealthy lifestyle choices, including poor nutrition, physical inactivity, and smoking, which heighten the risk of conditions like diabetes, heart disease, and obesity. Transplant diagnostics contribute to chronic disease management by facilitating precise monitoring of organ health and the early identification of transplant-related complications. These tools enhance patient outcomes by guiding timely interventions, supporting personalized treatment plans, and improving long-term organ survival and overall healthcare management. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Thus, the growing prevalence of chronic diseases is propelling the growth of the transplant diagnostics market.

How Are Segments Identified Within The Transplant Diagnostics Market Segment Framework?

The transplant diagnostics market covered in this report is segmented –

1) By Type: Reagent And Consumables, Instrument, Software And Services

2) By Transplant Type: Solid Organ, Stem Cell

3) By Organ: Kidney, Liver, Heart, Lung, Pancreas

4) By Technology: Non Molecular Assay, Molecular Assay

5) By End User: Hospitals And Transplant Centers, Research Laboratories AndTransplant Centers, Commercial Service Providers

Subsegments:

1) By Reagent And Consumables: PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials

2) By Instrument: Flow Cytometers, PCR Machines, Sequencers, Luminometers

3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services

Which Trends Are Expected To Impact The Transplant Diagnostics Market?

Leading companies within the transplant diagnostics market are focused on launching sophisticated transplant diagnostics services to maximize their market profitability. Advanced transplant diagnostic services encompass the utilization of novel and cutting-edge diagnostic tools and technologies to enhance the accuracy and efficiency of both pre-transplant and post-transplant testing. For instance, in March 2023, Quest Diagnostics, a US-based medical laboratory company, introduced Quest Advanced Specialized Transplant Services, a comprehensive collection of innovative diagnostics and support services designed to increase access to laboratory tests for solid organ, human cell, and tissue transplants. This offering features an extensive selection of more than 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test outcomes within a doctor’s electronic medical record (EMR), and round-the-clock support services, including medical consultation to ensure proper test selection and result interpretation impacting care. These new services build upon Quest’s prior offerings in transplant testing with added capabilities. Such capabilities include new patient-customized information packets to help educate patients on the procedure and to assist Quest’s phlebotomists in fast-tracking testing for patients visiting one of Quest’s 2,100 patient service centers. Results for some tests can be obtained within 8–24 hours.

Who Are The Companies Competing Within The Transplant Diagnostics Market?

Major companies operating in the transplant diagnostics market are F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc

Get The Full Transplant Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Which Region Leads The Transplant Diagnostics Market In Terms Of Market Share?

North America was the largest region in the transplant diagnostics market in 2025. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Transplant Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Transplant Diagnostics Market 2026, By The Business Research Company

Diagnostic Imaging Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/diagnostic-imaging-equipment-global-market-report

Diagnostic And Monitoring Ophthalmic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

Microbiology Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795